Johnson & Johnson will pay $20.4 million to settle claims by two Ohio counties, allowing the U.S. healthcare giant to avoid an upcoming federal trial seeking to hold the industry responsible for the nation’s opioid epidemic.
Drug companies urge appeals court to remove judge from U.S. opioid litigation
AmerisourceBergen, Business, Cardinal Health, CVS Health, District Judges, Drug Distributors, Government, Henry Schein, Hospitals, Lawsuits, Legal, McKesson, Opioid Litigation, Opioids, Retail Pharmacies, Rite Aid, U.S. Opioid Crisis, Wal-Mart Stores, Walgreens Boots AllianceEight drug companies urged a federal appeals court to disqualify the judge overseeing nationwide opioid litigation, in a last-ditch effort to avoid having him preside over a landmark trial.
Lawyers for cities and counties suing drug companies over the opioid epidemic objected to a bid by pharmaceutical distributors and pharmacies to disqualify the federal judge overseeing the cases, saying there is no basis and came too late.
U.S. government gives states nearly $2 billion to combat opioid crisis
Business, Department of Health and Human Services (HHS), Drug Distributors, Epidemics, Lawsuits, Legal, Opioid Overdoses, Opioids, Pharmacies, Substance Abuse and Mental Health Services Administration (SAMHSA) helpline, U.S. Centers for Disease Control and PreventionThe U.S. Department of Health and Human Services will offer states more than $1.8 billion in new funding to fight the opioid epidemic.
White House scraps proposal to lower U.S. drug prices
Analysts, Cigna, Consumers, CVS Health, Department of Health and Human Services (HHS), Health Insurance, Health Insurers, McKesson, Medicare, Prescription Drug Costs, Retail Pharmacies, Shares, Therapeutics, Trump Administration, UnitedHealth Group, Walgreens Boots Alliance, White HouseThe Trump administration scrapped a proposal for lowering prescription medicine prices, backing down from a policy that would have required health insurers to pass on billions of dollars in rebates they receive from drugmakers to Medicare patients.
Five U.S. states sue Purdue Pharma over marketing, selling of opioids
AmerisourceBergen, Business, Cardinal Health, Drug Distributors, Epidemics, Heroin, Heroin, Illegall Marketing & Selling, Iowa, Kansas, Lawsuits, Lawsuits, Maryland, McKesson, Opioids, Opioids, Painkillers, West Virginia, WisconsinFive U.S. states filed lawsuits accusing Purdue Pharma LP of illegally marketing and selling opioids, including OxyContin.
Drug distributor McKesson Corp. agreed to pay $37 million to resolve a lawsuit by the state of West Virginia seeking to hold the company responsible for contributing to the opioid epidemic, the state’s attorney general said.
U.S. President Donald Trump touted progress in the fight against opioid abuse and promised to hold drugmakers accountable for their part in the crisis, a day after his administration brought its first related criminal charges against a major drug distributor and company executives.
President Donald Trump is expected to tout his fight against opioid abuse in remarks in Atlanta a day after his administration brought its first related criminal charges against a major drug distributor and company executives.
